Fri, Aug 1, 2014, 8:03 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

InVivo Therapeutics Holdings Corp. Message Board

  • cynicoptimist cynicoptimist Feb 14, 2013 10:29 AM Flag

    FDA holding back science

    Just a quick comment. There's a lot of good in the FDA as it exists. No Thalidimide babys for 60 years.
    But the fact is that NVIV seems ready to hit the ground running, and this extended dialogue to work out minutia is not beneficial to medical progress at all. Think of all the SCI patients at the mercy of this red tape laden bureaucracy. InVivo is working on a hydrogel class of products to treat a host of indications, they are working with rodents for chronic SCI and future renditions of the scaffold, and yet they have to deal with clearance on the initial product which should already be helping the acutes. The FDA needs streamlining or the rest of the world will pass us by with new innovations.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
NVIV
0.93+0.01(+1.09%)Aug 1 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.